CFO transition
Genpact Limited CFO transition: Sumita Pandit to succeed Michael Weiner
Genpact Limited reported in a Form 8-K filed September 8, 2026 that Sumita Pandit will succeed Michael Weiner as Senior Vice President and Chief Financial Officer, effective September 9, 2026.
In the filing's words
On September 8, 2026, Genpact Limited (the “Company”) announced that Ms. Sumita Pandit, age 49, will become its new Senior Vice President and Chief Financial Officer, effective September 9, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Genpact Limited (G) |
|---|---|
| Event | Transition |
| Incoming | Sumita Pandit |
| Outgoing | Michael Weiner |
| Title in the filing | Senior Vice President and Chief Financial Officer |
| Effective | September 9, 2026 |
| 8-K filed | September 8, 2026 |
| Internal promotion | No |
| Prior role (per filing) | President and Chief Financial Officer, Radian |
| SEC CIK | 0001398659 |
Genpact Limited reported this change in a Form 8-K, Item 5.02, filed September 8, 2026. The filing's own words are quoted above.
Before and after at Genpact Limited
The adjacent records in the company's seat timeline.
Other records naming Michael Weiner
2The outgoing officer on this record, matched by name. Career line.
8 weeks ago· 2026-09-18DepartureG
Genpact LTD discloses CFO departure: Michael Weiner
2026-02-26 · 10-K signature
Michael Weiner signed Genpact LTD's annual report as Chief Financial Officer (Principal Financial Officer)
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Sumita Pandit? Send a correction with the primary source.